Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 20.16M | 7.16M | 16.36M | 17.26M | 8.46M |
Gross Profit | 1.01M | -3.14M | -15.55M | -15.66M | -7.42M |
EBITDA | 2.25M | -5.33M | 35.20M | -105.12M | -91.33M |
Net Income | -9.55M | -81.66M | -39.62M | -123.36M | -101.98M |
Balance Sheet | |||||
Total Assets | 28.65M | 53.96M | 133.44M | 169.79M | 192.53M |
Cash, Cash Equivalents and Short-Term Investments | 14.02M | 22.40M | 70.45M | 100.77M | 131.07M |
Total Debt | 35.76M | 38.48M | 38.86M | 45.40M | 41.08M |
Total Liabilities | 40.24M | 54.84M | 58.42M | 64.07M | 65.95M |
Stockholders Equity | -11.59M | -879.00K | 75.02M | 105.73M | 126.58M |
Cash Flow | |||||
Free Cash Flow | -31.77M | -63.34M | -89.02M | -109.66M | -96.39M |
Operating Cash Flow | -31.66M | -63.12M | -85.03M | -99.68M | -85.17M |
Investing Cash Flow | 22.15M | 58.55M | 104.75M | 19.07M | -63.82M |
Financing Cash Flow | -2.89M | -2.66M | -12.12M | 79.57M | 164.43M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
69 Neutral | $742.64M | ― | -4.48% | ― | 17.17% | 72.68% | |
59 Neutral | $298.20M | ― | -85.68% | ― | 19.68% | -13.17% | |
51 Neutral | $7.86B | -0.26 | -41.41% | 2.22% | 22.87% | -2.01% | |
49 Neutral | $7.97M | ― | -92.99% | ― | -1.88% | 23.99% | |
45 Neutral | $4.60M | ― | -440.77% | ― | -7.72% | 99.54% | |
42 Neutral | $11.45M | ― | -195.48% | ― | -40.47% | 96.14% | |
39 Underperform | $23.93K | ― | 406.89% | ― | ― | ― |
Acutus Medical has announced a significant downsizing, reducing its workforce by 70% to focus solely on fulfilling obligations to Medtronic for left-heart access products. This strategic move aims to cut costs while leveraging potential earnout payments from Medtronic until 2027. The transition will include operational changes and a shift in CEO and CFO roles, with the company continuing to support Medtronic through contract manufacturing. The downsizing is expected to be largely complete by Q1 2025.